Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Profound Medical (PROF) Revenue (2019 - 2026)

Profound Medical has reported Revenue over the past 7 years, most recently at $6.0 million for Q4 2025.

  • For Q4 2025, Revenue rose 43.13% year-over-year to $6.0 million; the TTM value through Dec 2025 reached $16.1 million, up 54.94%, while the annual FY2025 figure was $16.1 million, 50.73% up from the prior year.
  • Revenue for Q4 2025 was $6.0 million at Profound Medical, up from $5.3 million in the prior quarter.
  • Over five years, Revenue peaked at $6.0 million in Q4 2025 and troughed at -$3.4 million in Q4 2022.
  • A 5-year average of $2.1 million and a median of $2.0 million in 2022 define the central range for Revenue.
  • Biggest five-year swings in Revenue: crashed 442.69% in 2022 and later surged 489.0% in 2024.
  • Year by year, Revenue stood at $998000.0 in 2021, then crashed by 442.69% to -$3.4 million in 2022, then skyrocketed by 120.73% to $709000.0 in 2023, then surged by 489.0% to $4.2 million in 2024, then surged by 43.13% to $6.0 million in 2025.
  • Business Quant data shows Revenue for PROF at $6.0 million in Q4 2025, $5.3 million in Q3 2025, and $2.2 million in Q2 2025.